BioSyent Inc. (RX.V) has a MoatMap StockRank of 99/100 based on Quality (88/100), Value (47/100), and Momentum (66/100) factor scores. The current signal is STRONG BUY. BioSyent Inc. is a specialty pharmaceutical company with a high 'Quality' score, suggesting it may be a well-managed business. However, it does not have a clear, powerful, and asymmetric macro tailwind from the identified themes. While quality is important, the Druckenmiller lens prioritizes macro inflection points that are not fully priced by the market, which is absent here.
| Price | $10.14 |
| Market Cap | $116M |
| P/E (TTM) | 18.29 |
| P/E (Forward) | 25.48 |
| Price/Book | 3.88 |
| Return on Equity | 23.6% |
| Return on Invested Capital | 28.6% |
| Debt/Equity | 2.03 |
| Gross Margin | 76.6% |
| Operating Margin | 23.0% |
| Revenue Growth | 9.9% |
| Dividend Yield | 1.5% |
| Free Cash Flow | $4M |
BioSyent Inc. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (Canada).